Integrating Spot-Scanning Proton Arc Therapy With Functional Avoidance Strategies to Reduce Pulmonary Toxicity.
Document Type
Article
Publication Date
12-1-2025
Publication Title
Physics and Imaging in Radiation Oncology
Abstract
BACKGROUND AND PURPOSE: Functional avoidance radiotherapy has emerged as a promising technique using functional imaging to minimize pulmonary toxicity by reducing doses to functional lung. This study aims to investigate the potential dose-volume advantages of a novel spot-scanning proton arc (SPArc) therapy for functional avoidance radiotherapy with four-dimensional computed tomography (4DCT)-based ventilation imaging.
MATERIAL AND METHODS: Twenty-five patients from a prospective functional avoidance clinical trial treated with intensity-modulated photon radiotherapy were included. Robustly optimized intensity modulated proton therapy (IMPT) and SPArc plans were generated in RayStation. Functional lung contour was derived from the 4DCT-based ventilation imaging and utilized as an optimization structure in photon as well as IMPT and SPArc functional planning. The dose distributions were compared, and normal tissue complication probability (NTCP) models were applied to estimate the probability of pulmonary toxicity.
RESULTS: Using clinical photon plans as the baseline for comparison, both proton plans achieved equivalent target coverage and reduced dose to organs at risk. Compared with photon plans, the median absolute reduction of fV
CONCLUSIONS: Our study highlighted the potential of SPArc to spare dose to functional lung. NTCP results further indicated that the risk of pulmonary complications can be reduced with SPArc compared to photon or IMPT for functional avoidance radiotherapy.
Volume
36
First Page
100876
Last Page
100876
Recommended Citation
Chen Y, Liu P, Cong X, Castillo E, Castillo R, Grills I, et al.[Stevens C, Xu X, Li X, Ding X]. Integrating spot-scanning proton arc therapy with functional avoidance strategies to reduce pulmonary toxicity. Phys Imaging Radiat Oncol. 2025 Dec 1;36:100876. doi: 10.1016/j.phro.2025.100876. PMID: 41439248.
DOI
10.1016/j.phro.2025.100876
ISSN
2405-6316
PubMed ID
41439248